Recent News

• 04.17.2025 - PBH Opt-In Landing Page
• 04.09.2025 - 24th Annual Needham Virtual Healthcare Conference
• 04.09.2025 - 24th Annual Needham Virtual Healthcare Conference
• 04.09.2025 - Amylyx Pharmaceuticals Announces First Participant Dosed in Phase 1, Multiple Ascending Dose LUMINA Trial of AMX0114 in People Living with Amyotrophic Lateral Sclerosis
• 04.09.2025 - Amylyx Pharmaceuticals Announces First Participant Dosed in Phase 1, Multiple Ascending Dose LUMINA Trial of AMX0114 in People Living with Amyotrophic Lateral Sclerosis
• 04.02.2025 - Amylyx Pharmaceuticals to Present at the 24th Annual Needham Virtual Healthcare Conference
• 04.02.2025 - Amylyx Pharmaceuticals to Present at the 24th Annual Needham Virtual Healthcare Conference
• 03.10.2025 - Leerink's Global Biopharma Conference 2025
• 03.10.2025 - Leerink's Global Biopharma Conference 2025

Recent Filings

• 04.02.2025 - 4 Statement of changes in beneficial ownership of securities
• 04.02.2025 - 4 Statement of changes in beneficial ownership of securities
• 04.02.2025 - 4 Statement of changes in beneficial ownership of securities
• 04.02.2025 - 4 Statement of changes in beneficial ownership of securities
• 04.02.2025 - 4 Statement of changes in beneficial ownership of securities
• 03.26.2025 - EFFECT Notice of Effectiveness
• 03.24.2025 - 4 Statement of changes in beneficial ownership of securities
• 03.10.2025 - 4 Statement of changes in beneficial ownership of securities
• 03.10.2025 - 4 Statement of changes in beneficial ownership of securities
• 03.10.2025 - 4 Statement of changes in beneficial ownership of securities